Skip to Main Content
Table 3 —

Outcome measures of 238 unique type 2 diabetic patients at high risk (76% of 314 patients with postintervention data)

n*BaselineMean changeP
HbA1c 
 Experimental 63 9.2 ± 0.17 −1.1 ± 0.2 0.0001 
 Control 75 9.2 ± 0.14 −0.5 ± 0.2 0.006 
Systolic blood pressure (mmHg) 
 Experimental 62 163 ± 2.3 −18.5 ± 3.5 0.0001 
 Control 54 162 ± 2.5 −17.2 ± 2.9 0.0001 
Diastolic blood pressure (mmHg) 
 Experimental 24 96. ± 1.6 −15 ± 2.9 0.0001 
 Control 24 95 ± 1.5 −17.7 ± 3.7 0.0001 
Cholesterol (mmol/l) 
 Experimental 33 7.23 ± 0.17 −0.90 ± 0.23 0.0003 
 Control 30 7.25 ± 0.25 −0.75 ± 0.25 0.004 
n*BaselineMean changeP
HbA1c 
 Experimental 63 9.2 ± 0.17 −1.1 ± 0.2 0.0001 
 Control 75 9.2 ± 0.14 −0.5 ± 0.2 0.006 
Systolic blood pressure (mmHg) 
 Experimental 62 163 ± 2.3 −18.5 ± 3.5 0.0001 
 Control 54 162 ± 2.5 −17.2 ± 2.9 0.0001 
Diastolic blood pressure (mmHg) 
 Experimental 24 96. ± 1.6 −15 ± 2.9 0.0001 
 Control 24 95 ± 1.5 −17.7 ± 3.7 0.0001 
Cholesterol (mmol/l) 
 Experimental 33 7.23 ± 0.17 −0.90 ± 0.23 0.0003 
 Control 30 7.25 ± 0.25 −0.75 ± 0.25 0.004 

Data are means ± SEM.

*

The sum of this column (365) is greater than the number of unique patients with high risk factors (238) because many patients had more than one risk factor.

Close Modal

or Create an Account

Close Modal
Close Modal